Trial halted because effects not reported to ethics committee
BMJ 2003; 327 doi: https://doi.org/10.1136/bmj.327.7422.1010-e (Published 30 October 2003) Cite this as: BMJ 2003;327:1010
- Tony Sheldon
- Utrecht
A clinical trial into a new treatment for hepatitis C has been halted by a university hospital in the Netherlands after an internal investigation concluded that serious side effects were not reported to the hospital's medical ethics committee, nor were funds properly declared from personal agreements with commercial companies.
Four out of 19 trial patients experienced neurological damage in their limbs as a result of a combination of heat treatment and antiviral medication. One year later, one patient still has difficulty walking.
The Utrecht University …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.